Home・Lista de Ações・ResMed Inc

ResMed Inc

Fechado

SetorSaúde

224.78 2.18

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

215.7

Máximo

225.65

Indicadores-chave
By Trading Economics
Rendimento	1.1B 1.5B
Vendas	32M 1.5B
P/E Médio do Setor	20.319 57.002
EPS	2.95
Rendimento de Dividendos	1.13
Margem de lucro	104.075
Funcionários	10,600
EBITDA	-91M 493M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+8.12% upside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	1.13% 2.22%
Próximos Ganhos	29 de out. de 2026
Próxima data de dividendos	24 de set. de 2026
Próxima data de ex-dividendo	20 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	705M 32B
Abertura anterior	222.6
Fecho anterior	224.78

Sentimento de Notícias

By Acuity

72%

28%

299 / 340 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

11 de ago. de 2026, 23:26 UTC

Resmed Inc. shares remained roughly flat in after-market hours, reflecting broader market conditions amid investor caution ahead of upcoming inflation data.

10 de ago. de 2026, 20:02 UTC

Social Media

News

ResMed reported Q2 2026 sales of $1.46 billion, exceeding expectations. Shares are gaining today, despite earlier pulling back in the session.

8 de ago. de 2026, 00:01 UTC

Resmed Inc. shares declined in after-market trading, moving below the 20-day moving average, despite earlier gains since Friday's close.

7 de ago. de 2026, 23:41 UTC

News

ResMed shares declined after-market despite RBC Capital raising its price target to $244 and maintaining a Sector Perform rating.

6 de ago. de 2026, 23:01 UTC

News

ResMed shares declined in after-market trading despite a fourth-quarter earnings beat. The company reported a non-GAAP EPS of $2.95 and revenue of $1.46 billion.

5 de ago. de 2026, 19:11 UTC

News

ResMed Inc shares are higher as the company prepares for earnings on August 5, 2026, following a quarter that exceeded expectations.

4 de ago. de 2026, 20:02 UTC

News

ResMed Inc shares are advancing, supported by strong cash flow and global growth. The stock has maintained a notable gain since Monday's close.

3 de ago. de 2026, 21:02 UTC

News

ResMed Inc. shares are higher in after-market trading, supported by strong financials and a free cash flow margin of 31.7%.

31 de jul. de 2026, 21:01 UTC

Resmed Inc shares advanced in after-market trading, significantly above their 20-day moving average. No specific news was identified to explain the increase.

30 de jul. de 2026, 19:55 UTC

ResMed Inc's shares are declining today, diverging from a broader tech recovery. No specific news was identified to explain the move.

29 de jul. de 2026, 19:04 UTC

ResMed Inc's shares are higher Wednesday, reflecting overall upward momentum since Tuesday's close, despite a recent pullback from session highs.

28 de jul. de 2026, 19:02 UTC

Shares of Resmed Inc. are higher today, driven by gains in Health Care Equipment stocks. No specific news was identified to explain this increase.

27 de jul. de 2026, 22:26 UTC

Resmed Inc shares are trading higher in after-hours activity, remaining above their 20-day moving average despite no specific news driving the price movement.

24 de jul. de 2026, 16:03 UTC

ResMed Inc shares are higher today, driven by gains in the Health Care Equipment sub-sector, despite earlier volatility and recent underperformance.

22 de jul. de 2026, 23:16 UTC

Resmed Inc shares are trading higher in after-market hours, rebounding from an initial dip and showing unusual strength compared to typical performance.

21 de jul. de 2026, 20:56 UTC

Resmed Inc. shares are trading roughly flat after-market, amid broader market optimism following positive earnings from 3M and General Motors.

20 de jul. de 2026, 19:16 UTC

ResMed Inc shares are lower today, continuing a downward trend since Friday. The stock briefly hit a session high earlier but has since declined.

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

8.12% parte superior

Previsão para 12 meses

Média 237.91 USD 8.12%

Máximo 320 USD

Mínimo 213 USD

Com base em 14 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

14 ratings

Comprar

Manter

Vender

Com base em 14 analistas que deram avaliações de ações para ResMed Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

299 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.